PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia · Delayed Price · Currency is IDR 121.00
-1.00 (-0.82%)
Nov 5, 2026, 3:39 PM WIB
IDX:LABS Market Cap
IDX:LABS has a market cap or net worth of 473.4 billion as of November 4, 2026. It is the 34,550th most valuable company in the world and the 556th biggest in Indonesia. Its market cap has decreased by 16.77% in one year.
Market Cap
473.40B
Enterprise Value
494.11B
Revenue
214.40B
Global Rank
Country Rank
#556 Indonesia
PE Ratio
54.23
ChartMarket Cap Chart
Since July 10, 2024, IDX:LABS's market cap has decreased from 541.15B to 473.40B, a decrease of -12.52%. That is a compound annual growth rate of -5.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 473.40B | -12.52% |
| Dec 30, 2025 | 541.15B | 2.24% |
| Dec 30, 2024 | 529.30B | -2.19% |
| Jul 10, 2024 | 541.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 127.29T |
| PT Kalbe Farma Tbk. | 32.81T |
| PT Siloam International Hospitals Tbk | 24.68T |
| PT Mitra Keluarga Karyasehat Tbk | 18.06T |
| PT. Penta Valent Tbk | 561.47B |
| PT Itama Ranoraya Tbk | 524.72B |
| PT Royal Prima Tbk | 418.91B |
| PT Diastika Biotekindo Tbk | 395.27B |